Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review

BMC Research Notes

Lin Perry³  Janet Dunbabin²  Robyn Gallagher¹  Steven James⁴ 

[1] Charles Perkins Centre/Sydney Nursing School, University of Sydney, Sydney, New South Wales 2006, Australia;University of Newcastle, University Drive, Callaghan, New South Wales 2308, Australia;Faculty of Health, University of Technology, Sydney, 15 Broadway, Ultimo, New South Wales 2007, Australia;Huntsville District Memorial Hospital, Muskoka Algonquin Healthcare, 100 Frank Miller Drive, Huntsville, Ontario P1H 1H7, Canada

关键词: Type 1 diabetes;    Young adults;    Hypertension;    Nephropathy;    Retinopathy;    Predictors;    Prevalence;    Vascular complications;    Quantitative epidemiological systematic review;   

Others  :  1129907
DOI  :  10.1186/1756-0500-7-593

 received in 2014-01-09, accepted in 2014-08-04,  发布年份 2014

【 摘 要 】

Background

Vascular complications curtail life expectancy and quality of life in type 1 diabetes and development at younger ages is particularly detrimental. To date no review has summarised the prevalence or factors predicting their development in young adults.

Methods

A quantitative epidemiological systematic review was conducted to identify the prevalence and predictive factors for development of retinopathy, nephropathy and hypertension in young adults (sample age mean [plus 1SD] 18–30 years) with type 1 diabetes, using processes adapted from established review methods set out by the Centre for Reviews and Dissemination.

MEDLINE (Ovid), Scopus (Elsevier), CINAHL, Science Direct (Elsevier), Google Scholar and Cochrane databases were searched to identify relevant articles published between 1993 and June 2014. From this eleven papers were retrieved, appraised and results summarised by three reviewers using established methods.

Results

Some form of retinopathy occurred in up to almost half of participants; more severe forms affected up to one in ten. One in six was reported with microalbuminuria; one in 14 had macroalbuminuria. Hypertension occurred in almost one in two participants. Applying out-dated high thresholds this decreased to approximately one in ten participants. Glycaemic control was a consistent predictor of vascular disease in this age group.

Conclusion

Prevalence rates of retinopathy, nephropathy and hypertension in young adults with type 1 diabetes emphasise the importance of regular complication screening for early detection and treatment. The predictive effect of glycaemic control reinforces its importance for prevention of vascular complications.

【 授权许可】

   
2014 James et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]International Diabetes Federation: IDF Diabetes Atlas. Fifth edition. Brussels: International Diabetes Federation; 2011.
• [2]Catanzariti L, Faulks K, Moon L, Waters A, Flack J, Craig M: Australia's national trends in the incidence of Type 1 diabetes in 0–14 year olds, 2000–2006. Diabet Med 2009, 26(6):596-601.
• [3]Asao K, Sarti C, Forsen T, Hyttinen V, Nishimura R, Matsushima M: Long-term mortality in nationwide cohorts of children-onset type 1 diabetes in Japan and Finland. Diabetes Care 2003, 26:2037-2042.
• [4]Orchard T, Forrest K, Kuller L: Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2001, 24:1053-1059.
• [5]Soedamah-Muthu S, Fuller J, Mulnier H, Raleigh V, Lawrenson R, Colhoun H: All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 2006, 49:660-666.
• [6]Feltbower RG, Bodansky HJ, Patterson CC, Parslow RC, Stephenson CR, Reynolds C, McKinney PA: Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes. Results from the Yorkshire register of diabetes in children and young adults. Diabetes Care 2008, 31:922-926.
• [7]Shen G: Lipid disorders in diabetes mellitus and current management. Curr Pharm Anal 2007, 3:17-24.
• [8]Goldberg RB: Cardiovascular disease in patients who have diabetes. Cardiol Clin 2003, 21:399-413. vii
• [9]The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
• [10]Marshall S, Flyvbjerg A: Prevention and early detection of vascular complications of diabetes. Br Med J 2006, 333:475-480.
• [11]Blum R, Garell D, Hodgman C, Slap G: Transition from child-centered to adult health care systems for adolescents with chronic conditions: a Position Paper of the Society for Adolescent Medicine. J Adolesc Health 1993, 14:570-576.
• [12]Perry L, Lowe J, Steinbeck K, Dunbabin J: Services doing the best they can: service experiences of young adults with type 1 diabetes mellitus in rural Australia. J Clin Nurs 2012, 21(13–14):1955-1963.
• [13]Hatherly K, Smith L, Overland J, Johnston C, Brown-Singh L: Application of Australian clinical practice management guidelines: the current state of play in a sample of young people living with Type 1 diabetes in the state of New South Wales and the Australian Capital Territory. Diabetes Res Clin Pract 2011, 93(3):379-384.
• [14]Perry L, Steinbeck K, Dunbabin J, Lowe J: Lost in transition? Access to and uptake of adult health services and outcomes for young people with type 1 diabetes in regional New South Wales. Med J Aust 2010, 193(8):444-449.
• [15]Holmes-Walker D, Llewellyn A, Farrell K: A transition care programme which improves diabetes control and reduces hospital admission rates in young adults with Type 1 diabetes aged 15–25 years. Diabet Med 2007, 24:764-769.
• [16]Rapley P, Davidson P: Enough of the problem: a review of time for health care transition solutions for young adults with a chronic illness. J Clin Nurs 2010, 19:313-323.
• [17]Van Walleghem N, MacDonald C, Dean H: Evaluation of a systems navigator model for transition from pediatric to adult care for young adults with type 1 diabetes. Diabetes Care 2008, 31:1529-1530.
• [18]Renders C, Valk G, de Sonnaville J: Quality of care for patients with type 2 diabetes mellitus: a long-term comparison of two quality improvements programmes in the Netherlands. Diabet Med 2003, 20:846-852.
• [19]Shojania K, Ranjii S, McDonald K: Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta regression analysis. JAMA 2006, 296:427-440.
• [20]Van Dam H, Van der Horst F, Van den Bone B: Provider-patient interaction in diabetes care: effects on patient self-care and outcomes. A systematic review. Patient Educ Couns 2003, 51:17-28.
• [21]Centre for Reviews and Dissemination: Systematic Reviews. CRD’s guidance for undertaking reviews in health care. Centre for Reviews and Dissemination 2008.
• [22]Moher D, Liberati A, Tetzlaff J, DG A: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6(7):1-6.
• [23]American Diabetes Association: Standards of Medical Care in Diabetes - 2013. Diabetes Care 2013, 36(1):s11-s66.
• [24]Canadian Diabetes Association Clinical Practice Guidelines Expert Committee: Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2013, 37(Supp 1):s1-s212.
• [25]National Institute for Health and Clinical Excellence: Clinical Guideline 15. Type 1 Diabetes: Diagnosis and Management of Type 1 Diabetes in Children, Young People and Adults. London: National Institute for Health and Clinical Excellence; 2004.
• [26]Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Opthalmology 1985, 103:1796-1806.
• [27]Feris FL III: How effective are treatments for diabetic retinopathy? JAMA 1993, 269:1290-1291.
• [28]Murthy K, Murthy P, Kapur A, Owens D: Mobile diabetes eye care: experience in developing countries. Diabetes Res Clin Pract 2012, 97:343-349.
• [29]Sano H, Nishimura R, Asao K, Matsudaira T, Morimoto A, Agata T, Sjhimizu H, Tajima N: Blindness and laser photocoagulation in patients with childhood-onset type 1 diabetes in Japan. Br J Ophthalmol 2009, 93:726-730.
• [30]Kidney Disease Outcomes Quality Institute: K/DOQI clinical practice guidelines for chonic kidney disease: evaluation,classification, and stratification. Am J Kidney Dis 2002, 39(2 (Suppl 1)):s1-s266.
• [31]Arfken C, Reno P, Santiago J, Klein R: Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes. Diabetes Care 1998, 21(5):792-795.
• [32]Broe R, Rasmussen M, Frydkjaer-Olsen U, Olsen B, Mortensen H, Peto T, Grauslund J: The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: the Danish cohort of pediatric diabetes 1987 (DCPD1987). Acta Diabetol 2014, 51:413-420.
• [33]Garg S, Chase P, Icaza G, Rothman R, Osberg I, Cavmain J: 24-hour ambulatory blood pressure and renal disease ih young subjects with type 1 diabetes. J Diabetes Complications 1997, 11:263-267.
• [34]James S, Perry L, Gallagher R, Lowe J, Dunbabin J, McElduff P, Acharya S, Steinbeck K: Service usage and vascular complications in young adults with type 1 diabetes. BMC Endocr Disord 2014, 14(39):1-9.
• [35]Kullberg C, Abrahamsson M, Arnqvist H, Finnström K, Ludvigsson J: Prevalence of retinopathy differs with age at onset of diabetes in a population of patients with Type 1 diabetes. Diabet Med 2002, 19:924-931.
• [36]LeCaire T, Palta M, Zhang H, Allen C, Klein R, D’Alessio D: Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the First 4–14 years of type 1 diabetes. The Wisconsin Diabetes Registry Study. Am J Epidemiol 2006, 164:143-150.
• [37]Olsen B, Johannesen J, Sjolie A, Borch-Johnsen K, Hougaard P, Thorsteinsson B, Prammings S, Marinelli K, Mortensen H: Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Diabet Med 1999, 16:79-85.
• [38]Olsen B, Sjolie A, Hougaard P, Johannesen J, Marinelli K, Jacobsen B, Mortensen H: The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. J Diabetes Complications 2004, 18:160-164.
• [39]Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, Holl R: Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes. effect of diabetes duration, A1c, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007, 30:2523-2528.
• [40]Salardi S, Porta M, Maltoni G, Rubbi F, Rovere S, Cerutti F, Iafusco D, Tumini S, Calwin V: Infant and toddler type 1 diabetes: complications after 20 years duration. Diabetes Care 2012, 35:829-833.
• [41]Schwab K, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonnouri O, Beyer P, Holl R: Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes. Cross sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 2006, 29(2):218-225.
• [42]Whittemore R, Knafl K: The integrative review: updated methodology. J Adv Nurs 2005, 52(5):546-553.
• [43]STROBE: Strengthing the reporting of observational studies in epidemiology (STROBE) statement: checklist for cohort, case–control, and cross-sectional studies. 2007. available at http://www.strobe-statement.org/fileadmin/Stobe/uploads/checklists/STROBE_checklist_v4_combined.pdf webcite. Accessed 2nd May 2014
• [44]Schulz K, Altman D, Moher D: CONSORT statement: updated guidelines for reporting parallel group randomisation trials. Ann Intern Med 2010, 152:1-7.
• [45]Ng J, Morlet N: Improving the uptake of screening for diabetic retinopathy. Med J Aust 2013, 198(2):69-70.
• [46]Colagiuri S, Brnabic A, Gomez M, Fitzgerald B, Buckley A, Colagiuri R: DiabCo$t Australia Type 1: Assessing the Burden of Type 1 Diabetes in Australia. Canberra: Diabetes Australia; 2009.
• [47]Downie E, Craig M, Hing S, Cusumano J, Chan A, Donaghue K: Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes. Role of insulin therapy and glycemic control. Diabetes Care 2011, 34:2368-2373.
• [48]Karadeniz Z, Yilmaz M: Duration of diabetes and prevalence of diabetic retinopathy: Istanbul Diabetic Retinopathy Study - IDRS results. Diabetes Metab Syndr 2007, 1:43-48.
• [49]Esteves J, Kramer C, De Azevedo M, Stolz A, Roggia M, Larangeira A, Miozza S, Rosa C, Humberto Lambert J, Pecis M, Rodrigues T, Henrique Santos Canani L: Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Revista de Associacao Medica Brasileira 2009, 55(3):268-273.
• [50]Roy M: Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725. 1. Methodology, population, frequency of retinopathy, and visual impairment. Arch Opthalmology 2000, 11(1):97-104.
• [51]Diamante E: Renal involvement in type 1 (IDDM) diabetes in Spain. Diabetes Res Clin Pract 1997, 38:129-137.
• [52]Giorgino F, Laviola L, Perin P, Solnica B, Fuller J, Chaturvedi N: Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 2004, 47:1020-1028.
• [53]Rodrigues T, Henrique Canani L, Viatroski R, Hoffmann L, Esteves J, Gross J: Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract 2010, 87:240-245.
• [54]Romero-Aroca P, Fernández-Balart J, Baget-Bernaldiz M, Martinez-Salcedo I, Méndez-Marín I, Salvat-Serra M, Buil-Calvo J: Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients. J Diabetes Complications 2009, 23:229-238.
• [55]Romero-Aroca P, Sagarra-Alamo R, Baget-Bernaldiz M, Fernandez-Ballart J, Mendez-Marin I: Prevalence and relationship between diabetic retinopathy and nephropathy and its risk factors in the North-East of Spain. A population-based study. Ophthalmic Epidemiol 2010, 17(4):251-265.
• [56]Wallymahmed W, Morgan C, Gill G, Osman-Hicks V, Chamberlain P, MacFarlane I: Changes in cardiovascular risk factors in a type 1 diabetes population: a 3.5-year study. Pract Diabetes Int 2008, 25(6):223-227.
• [57]Maahs D, Kinney G, Wadwa P, Snell-Bergeon J, Dabelea D, Hokanson J, Eurlich J, Garg S, Eckel R, Rewers M: Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 2005, 28(2):301-306.
• [58]De Pablos-Velasco P, Martinez-Martin F, Aguilar J: Prevalence of hypertension in IDDM patients in the northern Grand Canary Island, according to the WHO/ISH and JNC-V/ADA criteria. Diabetes Res Clin Pract 1997, 38(13):191-197.
• [59]U.S. Department of Health and Human Services: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2004.
• [60]Cherry S, Benner J, Hussein M, Tang S, Nichol M: The clinical and economic burden of nonadherence with antihypertensive and lipid-lowering therapy in hypertensive patients. Value Health 2009, 12:489-497.
• [61]Hill M, Miller N, DeGeest S: ASH position paper: adherence and persistance with taking medication to control high blood pressure. J Clin Hypertens 2010, 12:757-764.
• [62]Laing S, Swerdlow A, Slater S: Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003, 46:760-765.
• [63]Craig M, Hattersley A, Donaghue K: Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes 2009, 10(Suppl 12):3-12.
• [64]Klein R, Knudtson M, Lee K, Gangnon R, Klein B: The Wisconsin epidemiologic study of diabetic retinopathy XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008, 115(11):1859-1868.
• [65]Dyer P, Lloyd C, Lancashire R, Bain S, Barnett A: Factors associated with clinic non-attendance in adults with type 1 diabetes mellitus. Diabet Med 1998, 15(4):339-343.